SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

FDC - Quaterly Results

28 May 2026 Evaluate
The revenue zoomed 17.09% to Rs. 5643.64 millions for the quarter ended March 2026 as compared to Rs. 4820.04 millions during the corresponding quarter last year.Net Profit witnessed a 122.07% growth almost the double from Rs. 482.15 millions to Rs. 1070.70  millions  of same quarter last year.The company reported a good operating profit of 1587.76 millions compared to 842.52 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 5643.64 4820.04 17.09 21263.27 20701.12 2.72 21263.27 20701.12 2.72
Other Income 471.64 314.26 50.08 1110.01 1055.18 5.20 1110.01 1055.18 5.20
PBIDT 1587.76 842.52 88.45 4631.81 4257.65 8.79 4631.81 4257.65 8.79
Interest 14.99 11.82 26.82 49.24 44.88 9.71 49.24 44.88 9.71
PBDT 1572.77 830.70 89.33 4374.68 4212.77 3.84 4374.68 4212.77 3.84
Depreciation 143.13 155.29 -7.83 591.04 536.06 10.26 591.04 536.06 10.26
PBT 1429.64 675.41 111.67 3783.64 3676.71 2.91 3783.64 3676.71 2.91
TAX 358.94 193.26 85.73 924.40 940.46 -1.71 924.40 940.46 -1.71
Deferred Tax 48.94 37.36 31.00 61.40 90.46 -32.12 61.40 90.46 -32.12
PAT 1070.70 482.15 122.07 2859.24 2736.25 4.49 2859.24 2736.25 4.49
Equity 162.81 162.81 0.00 162.81 162.81 0.00 162.81 162.81 0.00
PBIDTM(%) 28.13 17.48 60.95 21.78 20.57 5.91 21.78 20.57 5.91

FDC Share Price

411.30 9.65 (2.40%)
24-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1941.00
Dr. Reddys Labs. 1152.60
Cipla 1410.90
Lupin 2369.45
Zydus Lifesciences 1108.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: